Spots Global Cancer Trial Database for tgct
Every month we try and update this database with for tgct cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients | NCT04938180 | Tenosynovial Gi... Pigmented Villo... TGCT PVNS - Pigmente... | AMB-05X | 18 Years - | AmMax Bio, Inc. | |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor | NCT04192344 | Neoplasms Tenosynovial Gi... | ABSK021 | 18 Years - | Abbisko Therapeutics Co, Ltd | |
| Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) | NCT05417789 | TGCT | Emactuzumab Placebo | 12 Years - | SynOx Therapeutics Limited | |
| Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT | NCT05277454 | Advanced Malign... TGCT | HMPL-653 | 18 Years - 75 Years | Hutchmed | |
| A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan | NCT04703322 | Tenosynovial Gi... | Pexidartinib | 20 Years - | Daiichi Sankyo | |
| Exercise in Testicular Germ Cell Cancer Survivors | NCT05063760 | Testicular Germ... | aerobic-strengt... | 25 Years - 55 Years | Slovak Academy of Sciences | |
| A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan | NCT04703322 | Tenosynovial Gi... | Pexidartinib | 20 Years - | Daiichi Sankyo | |
| A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients | NCT04938180 | Tenosynovial Gi... Pigmented Villo... TGCT PVNS - Pigmente... | AMB-05X | 18 Years - | AmMax Bio, Inc. | |
| Study of Vimseltinib for Tenosynovial Giant Cell Tumor | NCT05059262 | Tenosynovial Gi... Pigmented Villo... Giant Cell Tumo... Tenosynovial Gi... Tenosynovial Gi... | vimseltinib Placebo | 18 Years - | Deciphera Pharmaceuticals LLC | |
| An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee | NCT04731675 | Tenosynovial Gi... Pigmented Villo... | AMB-05X | 18 Years - | AmMax Bio, Inc. | |
| A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan | NCT04703322 | Tenosynovial Gi... | Pexidartinib | 20 Years - | Daiichi Sankyo | |
| An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee | NCT04731675 | Tenosynovial Gi... Pigmented Villo... | AMB-05X | 18 Years - | AmMax Bio, Inc. | |
| A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen | NCT00341588 | Testicular Canc... | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | ||
| Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors | NCT01804530 | Solid Tumor Tumors of Any H... Tenosynovial Gi... | PLX7486 TsOH | 18 Years - | Plexxikon | |
| Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT | NCT05277454 | Advanced Malign... TGCT | HMPL-653 | 18 Years - 75 Years | Hutchmed | |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor | NCT04192344 | Neoplasms Tenosynovial Gi... | ABSK021 | 18 Years - | Abbisko Therapeutics Co, Ltd | |
| Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT) | NCT05417789 | TGCT | Emactuzumab Placebo | 12 Years - | SynOx Therapeutics Limited |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
